Home › Funds › Evelyn Partners Group Ltd › TEVA

Evelyn Partners Group Ltd position in TEVA

TEVA PHARMACEUTICAL INDS LTD · Health Care

Evelyn Partners Group Ltd reported holding 480 shares of TEVA (TEVA PHARMACEUTICAL INDS LTD) in its Q3 2026 13F filing — a position valued at US$234.0M, representing 3.74% of its reported portfolio and ranking #7 among its reported holdings. Evelyn Partners Group Ltd has disclosed TEVA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)480 sh
Reported value held$233.99M
Portfolio Weight3.74%
First reportedQ2 2026
Last changeHold
Updated2026-11-10

Last updated: 2026-11-10 · Source: SEC EDGAR Form 13F-HR

How Evelyn Partners Group Ltd's TEVA position evolved

Evelyn Partners Group Ltd first disclosed a stake in TEVA in Q2 2026 at 480 shares (US$16K). The position peaked in Q3 2026 at 480 shares, worth US$234.0M. Across 2 filings, Evelyn Partners Group Ltd held the position steady without any share-count change. The most recent filing (Q3 2026) shows 480 shares valued at US$234.0M.

Quarter by quarter

QuarterSharesValueChange
Q2 2026 480 $16.26K New
Q3 2026 480 $233.99M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TEVA and 13F data

TEVA (TEVA PHARMACEUTICAL INDS LTD) is a Health Care company. 42 other funds we track also report a position in TEVA — the largest reported positions include Harel Insurance Investments & Financial Services Ltd. (US$1.63B), Phoenix Financial Ltd. (US$1.45B), WCM INVESTMENT MANAGEMENT, LLC (US$1.38B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TEVA

All TEVA fund holders →

FAQ

How long has Evelyn Partners Group Ltd held TEVA?

Evelyn Partners Group Ltd has disclosed TEVA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Evelyn Partners Group Ltd's current position in TEVA?

As of Q3 2026, Evelyn Partners Group Ltd holds 480 shares of TEVA (TEVA PHARMACEUTICAL INDS LTD), valued at $233.99M, representing 3.74% of its reported portfolio and ranking #7.

Has Evelyn Partners Group Ltd been buying or selling TEVA?

In the latest 13F filing (Q3 2026), Evelyn Partners Group Ltd held unchanged its position in TEVA. The position peaked in Q3 2026 at 480 shares.

Which other funds hold TEVA?

Other major institutional holders of TEVA include Harel Insurance Investments & Financial Services Ltd., Phoenix Financial Ltd., WCM INVESTMENT MANAGEMENT, LLC, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.